Literature DB >> 322843

Cancer and occupation: status and needs of epidemiologic research.

P Cole.   

Abstract

In the United States about 15% of cancer in men and 5% of cancer in women is probably due to occupational exposures. Yet, among the populations actually exposed, occupational cancer is a major health hazard. Further, occupational carcinogenesis should be studied because of it scientific interest and the likely generalizability of findings to non-occupational exposures. The alert clinician remains the most important source of leads to occupational cancer. When groups of cases occur, particularly cases of rare tumors among relatively young persons, an occupational exposure should be suspect. A reasonably detailed occupation history should be included in every medical record. Formal evaluation, measurement of risk and identification of specific hazards is usually done by epidemiologic methods. Several approaches to the improvement of these methods and, possibly, to disease control are presented.

Entities:  

Mesh:

Year:  1977        PMID: 322843     DOI: 10.1002/1097-0142(197704)39:4+<1788::aid-cncr2820390807>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  The proportion of cancer attributable to occupational exposures.

Authors:  Mark P Purdue; Sally J Hutchings; Lesley Rushton; Debra T Silverman
Journal:  Ann Epidemiol       Date:  2014-11-13       Impact factor: 3.797

2.  The relevance of occupational medicine.

Authors:  B Walker
Journal:  J Natl Med Assoc       Date:  1982-04       Impact factor: 1.798

3.  Future etiologic research in occupational cancer.

Authors:  J Siemiatycki
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

Review 4.  Known occupational carcinogens and their significance.

Authors:  P Ernst; G Thériault
Journal:  Can Med Assoc J       Date:  1984-04-01       Impact factor: 8.262

5.  Occupational cancer in Canada: what do we know?

Authors:  K Teschke; M C Barroetavena
Journal:  CMAJ       Date:  1992-11-15       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.